Selected research
Industry Growth & Trends
Global Drug Repurposing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Drug Repurposing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Drug Repurposing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Drug Repurposing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drug Repurposing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Drug Repurposing market include Novartis, Pfizer, AbbVie, NuMedii, Biovista, Astellas Pharma and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Drug Repurposing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Drug Repurposing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Repurposing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Repurposing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Drug Repurposing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Drug Repurposing Market by Company
Novartis
Pfizer
AbbVie
NuMedii
Biovista
Astellas Pharma
Allergan
Drug Repurposing Segment by Type
Neurodegenerative Diseases
CNS Diseases
Oncology
Others
Drug Repurposing Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Drug Repurposing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Repurposing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Repurposing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Repurposing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drug Repurposing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Neurodegenerative Diseases
- CNS Diseases
- Oncology
- Others
Applications
- Hospitals
- Ambulatory Surgical Centers
- Others
Companies covered
- Novartis
- Pfizer
- AbbVie
- NuMedii
- Biovista
- Astellas Pharma
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Drug Repurposing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Drug Repurposing Market Size by Region (2021-2032)
- 1.4.1 Global Drug Repurposing Market Size by Region (2021-2026)
- 1.4.2 Global Drug Repurposing Market Size by Region (2027-2032)
- 1.5 Key Regions Drug Repurposing Market Size (2021-2032)
- 1.5.1 North America Drug Repurposing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Drug Repurposing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Drug Repurposing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Drug Repurposing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Drug Repurposing Market Size Growth Rate (2021-2032)
2 Drug Repurposing Market by Type
- 2.1 Type Introduction
- 2.1.1 Neurodegenerative Diseases
- 2.1.2 CNS Diseases
- 2.1.3 Oncology
- 2.1.4 Others
- 2.2 Global Drug Repurposing Market Size by Type
- 2.2.1 Global Drug Repurposing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Drug Repurposing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Drug Repurposing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Drug Repurposing Market Size by Regions
- 2.3.1 North America Drug Repurposing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Drug Repurposing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Drug Repurposing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Drug Repurposing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Drug Repurposing Market Size Breakdown by Type (2021-2026)
3 Drug Repurposing Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospitals
- 3.1.2 Ambulatory Surgical Centers
- 3.1.3 Others
- 3.2 Global Drug Repurposing Market Size by Application
- 3.2.1 Global Drug Repurposing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Drug Repurposing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Drug Repurposing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Drug Repurposing Market Size by Regions
- 3.3.1 North America Drug Repurposing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Drug Repurposing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Drug Repurposing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Drug Repurposing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Drug Repurposing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Drug Repurposing Industry Trends
- 4.2 Drug Repurposing Industry Drivers
- 4.3 Drug Repurposing Industry Opportunities and Challenges
- 4.4 Drug Repurposing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Drug Repurposing Revenue (2021-2026)
- 5.2 Global Drug Repurposing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Drug Repurposing Key Company Headquarters & Area Served
- 5.4 Global Drug Repurposing Company, Product Type & Application
- 5.5 Global Drug Repurposing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Drug Repurposing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Drug Repurposing Players Market Share by Revenue in 2025
- 5.6.3 2025 Drug Repurposing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis Drug Repurposing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novartis Drug Repurposing Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer Drug Repurposing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Pfizer Drug Repurposing Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 AbbVie
- 6.3.1 AbbVie Company Information
- 6.3.2 AbbVie Business Overview
- 6.3.3 AbbVie Drug Repurposing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 AbbVie Drug Repurposing Product Portfolio
- 6.3.5 AbbVie Recent Developments
- 6.4 NuMedii
- 6.4.1 NuMedii Company Information
- 6.4.2 NuMedii Business Overview
- 6.4.3 NuMedii Drug Repurposing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 NuMedii Drug Repurposing Product Portfolio
- 6.4.5 NuMedii Recent Developments
- 6.5 Biovista
- 6.5.1 Biovista Company Information
- 6.5.2 Biovista Business Overview
- 6.5.3 Biovista Drug Repurposing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Biovista Drug Repurposing Product Portfolio
- 6.5.5 Biovista Recent Developments
- 6.6 Astellas Pharma
- 6.6.1 Astellas Pharma Company Information
- 6.6.2 Astellas Pharma Business Overview
- 6.6.3 Astellas Pharma Drug Repurposing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Astellas Pharma Drug Repurposing Product Portfolio
- 6.6.5 Astellas Pharma Recent Developments
- 6.7 Allergan
- 6.7.1 Allergan Company Information
- 6.7.2 Allergan Business Overview
- 6.7.3 Allergan Drug Repurposing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Allergan Drug Repurposing Product Portfolio
- 6.7.5 Allergan Recent Developments
7 North America
- 7.1 North America Drug Repurposing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Drug Repurposing Market Size by Country (2021-2026)
- 7.3 North America Drug Repurposing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Drug Repurposing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Drug Repurposing Market Size by Country (2021-2026)
- 8.3 Europe Drug Repurposing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Repurposing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Drug Repurposing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Drug Repurposing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Drug Repurposing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Drug Repurposing Market Size by Country (2021-2026)
- 10.3 South America Drug Repurposing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Repurposing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Drug Repurposing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Drug Repurposing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst